Andre van As

22 papers receiving 1.9k citations

Andre van As's Hit Papers

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma 2001 · 1.1k citations
1.1k0+8+16Years since publication2505007501k

Peers

Andre van As
Comparison fields: 5 of 76
  • Physiology 1.5k
  • Immunology and Allergy 254
  • Rehabilitation 107
  • Otorhinolaryngology 44
  • Pulmonary and Respiratory Medicine 179
Replace Anjuli S. Nayak with:
Anjuli S. Nayak United States
Andrew M. Wootton Australia
William C. Howland United States
Harold B. Kaiser United States
Graeme P. Currie United Kingdom
Steven F. Weinstein United States
Bruce M. Prenner United States
Frank C. Hampel United States
Wolfgang Timmer Germany
Theodore F. Reiss United States
Andre van As relative to Anjuli S. Nayak United States Anjuli S. Nayak's profile →
Citations per field
00.5×10×20×30×35.7×
Anjuli S. Nayak · 1×
Citations per year

Countries citing papers authored by Andre van As

Since Specialization
Citations

This map shows the geographic impact of Andre van As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andre van As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andre van As more than expected).

Fields of papers citing papers by Andre van As

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andre van As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andre van As. The network helps show where Andre van As may publish in the future.

Co-authors

The 25 scholars most cited alongside Andre van As, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andre van As Line = papers co-authored together Andre van As links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
Hit paper breakdown →
20011078
2 1992299
3 1994147
4 198791
5 199374
6 199470
7 200756
8
Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.
199148
9 200742
10 198941
11 198737
12 200635
13 199627
14 199021
15 199416
16 198214
17 199413
18 199310
19 19869
20 19917

About Andre van As

Andre van As is a scholar working on Physiology, Immunology and Allergy, Rehabilitation, Complementary and alternative medicine and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 2.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (5 papers), Exercise and Physiological Responses (2 papers), Cardiovascular and exercise physiology (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Physiology (1.5k citations), Immunology and Allergy (254 citations), Rehabilitation (107 citations), Otorhinolaryngology (44 citations) and Pulmonary and Respiratory Medicine (179 citations). Andre van As has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include William W. Busse, Giovanni Della Cioppa, Bobby Quentin Lanier, Niroo Gupta, Angel FowlerTaylor, Jonathan Corren, Robert J. Dockhorn, Paul Chervinsky, Edwin A. Bronsky and James P. Kemp. Their work appears in journals such as Journal of Allergy and Clinical Immunology, CHEST Journal, European Respiratory Journal, Respiratory Medicine and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact